Editor(s):

(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.

Reviewers:

(1) S. Murugesan, National Institute of Siddha, India.

(2) Manoj Kumar, St. Xavier’s College, India.

(3) Dinesh P. Hase, Amrutvahini College of Pharmacy, Savitribai Phule Pune University, India.

Additional Reviewers:

Additional Reviewers: (Comments received after deadline)

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.66/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

---

Stage 1 | Original Manuscript | File 1 | NA

---

Stage 2 | Peer Review Report_1 (S. Murugesan, India) | File 1 | File 2

---

Stage 2 | Peer Review Report_2 (Manoj Kumar, India) | File 1 | File 2

---

Stage 2 | Peer Review Report_3 (Dinesh P. Hase, India) | File 1 | NA

---

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

---

Stage 2 | Re-Review report_1_v1 (S. Murugesan, India) | File 1 | NA

---

Stage 2 | Re-Review report_2_v1 (Manoj Kumar, India) | File 1 | NA

---

Stage 2 | Revised_MS_v2_and_Feedback_v2 | File 1 | File 2

---

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

---